Sangamo Therapeutics
SGMO
#8841
Rank
โ‚ฌ0.12 B
Marketcap
0,38ย โ‚ฌ
Share price
3.81%
Change (1 day)
-83.37%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -โ‚ฌ97.81 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ32.87 Million. In 2024 the company made an earning of -โ‚ฌ84.01 Million, an increase over its 2023 earnings that were of -โ‚ฌ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ97.81 Million16.42%
2024 -โ‚ฌ84.01 Million-17.27%
2023 -โ‚ฌ0.11 Billion-40.88%
2022 -โ‚ฌ0.18 Billion9.79%
2021 -โ‚ฌ0.16 Billion41.52%
2020 -โ‚ฌ0.12 Billion23.17%
2019 -โ‚ฌ89.76 Million36.33%
2018 -โ‚ฌ65.84 Million36.89%
2017 -โ‚ฌ48.1 Million-22.32%
2016 -โ‚ฌ61.92 Million54.86%
2015 -โ‚ฌ39.99 Million75.62%
2014 -โ‚ฌ22.77 Million0.13%
2013 -โ‚ฌ22.74 Million
2011 -โ‚ฌ30.57 Million43.66%
2010 -โ‚ฌ21.28 Million28.52%
2009 -โ‚ฌ16.56 Million-23.55%
2008 -โ‚ฌ21.66 Million2.45%
2007 -โ‚ฌ21.14 Million19.5%
2006 -โ‚ฌ17.69 Million50.78%
2005 -โ‚ฌ11.74 Million75%
2004 -โ‚ฌ6.71 Million-33.25%
2003 -โ‚ฌ10.05 Million-62.27%
2002 -โ‚ฌ26.62 Million102.82%
2001 -โ‚ฌ13.13 Million23.21%
2000 -โ‚ฌ10.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚ฌ8.43 B-9,167.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ0.11 B-219.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.03 B-7,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ1.62 B-1,846.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚ฌ0.64 Billion 582.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.64 B-29,814.01%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.57 B-723.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.70 B-21,278.43%๐Ÿ‡บ๐Ÿ‡ธ USA